ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.

Liu, Bo; Liu, Zhaoqi; Chen, Sisi; Ki, Michelle; Erickson, Caroline; Reis-Filho, Jorge S; Durham, Benjamin H; Chang, Qing; de Stanchina, Elisa; Sun, Yiwei; Rabadan, Raul; Abdel-Wahab, Omar; Chandarlapaty, Saratcolumbia University; new
Journal of Clinical Investigation2021-1-4DOI: 10.1172/JCI138315
16阅读
引用收藏
分享

摘要

Mutations in the core RNA splicing factor SF3B1 are prevalent in leukemias and uveal melanoma, but hotspot SF3B1 mutations are also seen in epithelial malignancies such as breast cancer. Although hotspot mutations in SF3B1 alter hematopoietic differentiation, whether SF3B1 mutations contribute to epithelial cancer development and progression is unknown. Here, we identify that SF3B1 mutations in mammary epithelial and breast cancer cells induce a recurrent pattern of aberrant splicing leading to activation of AKT and NF-κB, enhanced cell migration, and accelerated tumorigenesis. Transcriptomic analysis of human cancer specimens, MMTV-cre Sf3b1K700E/WT mice, and isogenic mutant cell lines identified hundreds of aberrant 3' splice sites (3'ss) induced by mutant SF3B1. Consistently between mouse and human tumors, mutant SF3B1 promoted aberrant splicing (dependent on aberrant branchpoints as well as pyrimidines downstream of the cryptic 3'ss) and consequent suppression of PPP2R5A and MAP3K7, critical negative regulators of AKT and NF-κB. Coordinate activation of NF-κB and AKT signaling was observed in the knockin models, leading to accelerated cell migration and tumor development in combination with mutant PIK3CA but also hypersensitizing cells to AKT kinase inhibitors. These data identify hotspot mutations in SF3B1 as an important contributor to breast tumorigenesis and reveal unique vulnerabilities in cancers harboring them.

学科与关键词

关键词
Breast cancerOncologyRNA processing
相关
加载中…
  • Aurora kinase A regulates cancer-associated RNA aberrant splicing in breast cancer
    Li, Sisi*; Qi, Yangfan; Yu, Jiachuan; Hao, Yuchao; Xu, Lingzhi; Ding, Xudong; Zhang, Minghui*; Geng, Jingshu*Heliyon, 2023, 9(7): e17386.被引 1
  • Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence
    Yu, Le*; Zhou, Dan; Zhang, Guiming; Ren, Zhonglu; Luo, Xin; Liu, Peng; Plouffe, Steven W.; Meng, Zhipeng; Moroishi, Toshiro; Li, Yilei; Zhang, Yiyue; Brown, Joan Heller; Liu, Shuwen*; Guan, Kun-Liang*Molecular Oncology, 2022, 16(3): 607-629.被引 6
  • Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome
    Jinhua Piao; Naoto Sakurai; Shotaro Iwamoto; Junji Nishioka; Kaname Nakatani; Yoshihiro Komada; Shuki Mizutani; Masatoshi TakagiMolecular Carcinogenesis, 2012, n/a-n/a.
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Clinical Investigation
发表日期
2021-01-04
卷期
第 131 卷, 第 1 期
DOI
10.1172/JCI138315
语言
ENGLISH
期刊收录
NSL.NATURE-INDEX
期刊等级
1区
成果收录
PUBMED

作者

  • L

    Liu, Bo (第一作者)

    new

  • L

    Liu, Zhaoqi

    columbia university · new

查看全部 13 位作者收起作者
  • C

    Chen, Sisi

    new

  • K

    Ki, Michelle

    new

  • E

    Erickson, Caroline

    new

  • R

    Reis-Filho, Jorge S

  • D

    Durham, Benjamin H

    new

  • C

    Chang, Qing

  • d

    de Stanchina, Elisa

  • S

    Sun, Yiwei

    columbia university · new

  • R

    Rabadan, Raul

    columbia university · new

  • A

    Abdel-Wahab, Omar

    new

  • C

    Chandarlapaty, Sarat

    new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417